PFE logo

Pfizer Inc. (PFE) Cash From Investing

Annual CFI:

$2.65B+$34.93B(+108.22%)
December 31, 2024

Summary

  • As of today, PFE annual cash from investing is $2.65 billion, with the most recent change of +$34.93 billion (+108.22%) on December 31, 2024.
  • During the last 3 years, PFE annual cash from investing has risen by +$25.20 billion (+111.76%).
  • PFE annual cash from investing is now -56.91% below its all-time high of $6.15 billion, reached on December 31, 2012.

Performance

PFE Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Quarterly CFI:

$3.95B+$677.00M(+20.68%)
June 29, 2025

Summary

  • As of today, PFE quarterly cash from investing is $3.95 billion, with the most recent change of +$677.00 million (+20.68%) on June 29, 2025.
  • Over the past year, PFE quarterly cash from investing has dropped by -$649.00 million (-14.11%).
  • PFE quarterly cash from investing is now -59.13% below its all-time high of $9.67 billion, reached on March 1, 2018.

Performance

PFE Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM CFI:

$3.54B-$649.00M(-15.47%)
June 29, 2025

Summary

  • As of today, PFE TTM cash from investing is $3.54 billion, with the most recent change of -$649.00 million (-15.47%) on June 29, 2025.
  • Over the past year, PFE TTM cash from investing has increased by +$7.32 billion (+193.88%).
  • PFE TTM cash from investing is now -42.40% below its all-time high of $6.15 billion, reached on December 31, 2012.

Performance

PFE TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

PFE Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+108.2%-14.1%+193.9%
3Y3 Years+111.8%+134.9%+115.1%
5Y5 Years+167.2%+130.4%+123.0%

PFE Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+108.2%-14.1%+115.5%-15.5%+110.5%
5Y5-Yearat high+108.2%-52.6%+115.5%-15.5%+110.5%
All-TimeAll-Time-56.9%+108.2%-59.1%+115.5%-42.4%+110.5%

PFE Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.95B(+20.7%)
$3.54B(-15.5%)
Mar 2025
-
$3.27B(+301.7%)
$4.19B(+58.1%)
Dec 2024
$2.65B(+108.2%)
-$1.62B(+21.1%)
$2.65B(+139.5%)
Sep 2024
-
-$2.06B(-144.7%)
-$6.72B(-78.0%)
Jun 2024
-
$4.60B(+165.6%)
-$3.78B(+88.8%)
Mar 2024
-
$1.73B(+115.8%)
-$33.86B(-4.9%)
Dec 2023
-$32.28B(-63.5%)
-$11.00B(-1338.3%)
-$32.28B(-25.6%)
Sep 2023
-
$888.00M(+103.5%)
-$25.69B(+17.6%)
Jun 2023
-
-$25.48B(-868.8%)
-$31.17B(-83.4%)
Mar 2023
-
$3.31B(+175.2%)
-$17.00B(+13.9%)
Dec 2022
-$19.74B(+12.4%)
-$4.41B(+3.9%)
-$19.74B(-10.2%)
Sep 2022
-
-$4.59B(+59.5%)
-$17.92B(+23.4%)
Jun 2022
-
-$11.31B(-2095.2%)
-$23.41B(-15.7%)
Mar 2022
-
$567.00M(+121.9%)
-$20.23B(+10.3%)
Dec 2021
-$22.55B(-427.9%)
-$2.59B(+74.3%)
-$22.55B(-93.9%)
Sep 2021
-
-$10.08B(-23.8%)
-$11.63B(-983.9%)
Jun 2021
-
-$8.14B(-365.8%)
-$1.07B(+82.0%)
Mar 2021
-
-$1.75B(-121.0%)
-$5.95B(-39.2%)
Dec 2020
-$4.27B(-8.3%)
$8.33B(+1631.8%)
-$4.27B(+72.3%)
Sep 2020
-
$481.00M(+103.7%)
-$15.43B(+31.9%)
Jun 2020
-
-$13.01B(>-9900.0%)
-$22.68B(-96.0%)
Mar 2020
-
-$71.00M(+97.5%)
-$11.57B(-193.2%)
Dec 2019
-$3.94B(-187.2%)
-$2.83B(+58.1%)
-$3.94B(-110.3%)
Sep 2019
-
-$6.76B(-255.4%)
-$1.88B(-194.7%)
Jun 2019
-
-$1.90B(-125.2%)
$1.98B(-17.8%)
Mar 2019
-
$7.55B(+1088.2%)
$2.41B(-46.8%)
Dec 2018
$4.53B(+195.5%)
-$764.00M(+73.7%)
$4.53B(+785.5%)
Sep 2018
-
-$2.90B(-97.0%)
$511.00M(+20.8%)
Jun 2018
-
-$1.47B(-115.2%)
$423.00M(+172.9%)
Mar 2018
-
$9.67B(+302.3%)
$155.00M(+103.3%)
Dec 2017
-$4.74B(+39.3%)
-$4.78B(-59.7%)
-$4.74B(-54.4%)
Sep 2017
-
-$2.99B(-71.8%)
-$3.07B(+31.2%)
Jun 2017
-
-$1.74B(-136.5%)
-$4.46B(+39.7%)
Mar 2017
-
$4.77B(+253.6%)
-$7.39B(+5.3%)
Dec 2016
-$7.81B(-162.1%)
-$3.11B(+29.1%)
-$7.81B(-12.7%)
Sep 2016
-
-$4.38B(+6.3%)
-$6.93B(+11.1%)
Jun 2016
-
-$4.68B(-207.4%)
-$7.79B(-49.3%)
Mar 2016
-
$4.36B(+295.7%)
-$5.22B(-75.0%)
Dec 2015
-$2.98B(+47.3%)
-$2.23B(+57.6%)
-$2.98B(-31.3%)
Sep 2015
-
-$5.24B(-149.1%)
-$2.27B(-618.3%)
Jun 2015
-
-$2.10B(-131.9%)
$438.00M(-57.7%)
Mar 2015
-
$6.59B(+535.4%)
$1.04B(+118.3%)
Dec 2014
-$5.65B(+46.8%)
-$1.51B(+40.3%)
-$5.65B(-39.3%)
Sep 2014
-
-$2.54B(-68.2%)
-$4.06B(-90.1%)
Jun 2014
-
-$1.51B(-1437.8%)
-$2.14B(-1131.9%)
Mar 2014
-
-$98.00M(-222.5%)
$207.00M(+101.9%)
Dec 2013
-$10.63B(-272.7%)
$80.00M(+113.1%)
-$10.63B(-174.7%)
Sep 2013
-
-$611.00M(-173.1%)
-$3.87B(-10.4%)
Jun 2013
-
$836.00M(+107.6%)
-$3.50B(+33.0%)
Mar 2013
-
-$10.93B(-259.9%)
-$5.23B(-184.9%)
Dec 2012
$6.15B(+233.9%)
$6.84B(+2868.0%)
$6.15B(+2749.1%)
Sep 2012
-
-$247.00M(+72.2%)
$216.00M(-68.1%)
Jun 2012
-
-$887.00M(-296.7%)
$678.00M(-64.8%)
Mar 2012
-
$451.00M(-49.8%)
$1.93B(-12.5%)
Dec 2011
$1.84B(+474.6%)
$899.00M(+318.1%)
$2.20B(+150.6%)
Sep 2011
-
$215.00M(-40.4%)
-$4.34B(+48.5%)
Jun 2011
-
$361.00M(-50.2%)
-$8.44B(+7.9%)
Mar 2011
-
$725.00M(+112.8%)
-$9.16B(-1762.0%)
Dec 2010
-$492.00M(+98.4%)
-$5.64B(-45.5%)
-$492.00M(-162.6%)
Sep 2010
-
-$3.88B(-974.8%)
$786.00M(-82.0%)
Jun 2010
-
-$361.00M(-103.8%)
$4.37B(+153.0%)
Mar 2010
-
$9.39B(+315.1%)
-$8.24B(+73.6%)
Dec 2009
-$31.27B(-143.6%)
-$4.37B(-1365.4%)
-$31.27B(-5.3%)
Sep 2009
-
-$298.00M(+97.7%)
-$29.68B(+2.7%)
Jun 2009
-
-$12.97B(+4.8%)
-$30.49B(-45.3%)
Mar 2009
-
-$13.63B(-390.4%)
-$20.98B(-63.5%)
Dec 2008
-$12.84B(-1714.5%)
-$2.78B(-151.1%)
-$12.84B(+0.1%)
Sep 2008
-
-$1.11B(+68.0%)
-$12.85B(-9.9%)
Jun 2008
-
-$3.46B(+36.8%)
-$11.70B(-30.6%)
Mar 2008
-
-$5.48B(-95.9%)
-$8.96B(-1227.0%)
Dec 2007
$795.00M(-84.4%)
-$2.80B(-6055.3%)
$795.00M(-80.3%)
Sep 2007
-
$47.00M(+106.5%)
$4.03B(-6.9%)
Jun 2007
-
-$724.00M(-117.0%)
$4.33B(+9.8%)
Mar 2007
-
$4.27B(+881.8%)
$3.94B(-22.7%)
Dec 2006
$5.10B
$435.00M(+26.5%)
$5.10B(+263.9%)
Sep 2006
-
$344.00M(+131.0%)
-$3.11B(+36.7%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$1.11B(-120.4%)
-$4.92B(-261.5%)
Mar 2006
-
$5.43B(+169.8%)
$3.04B(+160.0%)
Dec 2005
-$5.07B(+46.2%)
-$7.78B(-432.1%)
-$5.07B(>-9900.0%)
Sep 2005
-
-$1.46B(-121.3%)
$18.00M(-98.8%)
Jun 2005
-
$6.86B(+355.2%)
$1.52B(+118.1%)
Mar 2005
-
-$2.69B(+0.1%)
-$8.39B(+11.0%)
Dec 2004
-$9.42B(-294.2%)
-$2.69B(-7367.6%)
-$9.42B(-61.5%)
Sep 2004
-
$37.00M(+101.2%)
-$5.83B(-1.2%)
Jun 2004
-
-$3.05B(+18.1%)
-$5.76B(-292.2%)
Mar 2004
-
-$3.72B(-513.9%)
$3.00B(-38.2%)
Dec 2003
$4.85B(+211.8%)
$899.00M(+748.1%)
$4.85B(+44.0%)
Sep 2003
-
$106.00M(-98.1%)
$3.37B(+36.4%)
Jun 2003
-
$5.72B(+405.8%)
$2.47B(+148.1%)
Mar 2003
-
-$1.87B(-220.0%)
-$5.13B(-18.3%)
Dec 2002
-$4.34B(+40.2%)
-$584.00M(+26.4%)
-$4.34B(+25.7%)
Sep 2002
-
-$793.00M(+57.9%)
-$5.84B(+9.8%)
Jun 2002
-
-$1.89B(-75.2%)
-$6.47B(+8.5%)
Mar 2002
-
-$1.08B(+48.3%)
-$7.07B(+2.5%)
Dec 2001
-$7.25B(-93.3%)
-$2.08B(-46.3%)
-$7.25B(-30.4%)
Sep 2001
-
-$1.42B(+42.7%)
-$5.56B(+6.2%)
Jun 2001
-
-$2.49B(-97.5%)
-$5.93B(-20.1%)
Mar 2001
-
-$1.26B(-220.4%)
-$4.94B(-31.5%)
Dec 2000
-$3.75B(-35.6%)
-$393.00M(+78.1%)
-$3.75B(-6.0%)
Sep 2000
-
-$1.79B(-19.9%)
-$3.54B(-28.6%)
Jun 2000
-
-$1.49B(-1892.0%)
-$2.75B(-51.3%)
Mar 2000
-
-$75.00M(+58.8%)
-$1.82B(+34.2%)
Dec 1999
-$2.77B(-726.3%)
-$182.00M(+81.9%)
-$2.77B(+32.5%)
Sep 1999
-
-$1.00B(-79.1%)
-$4.10B(-151.5%)
Jun 1999
-
-$560.00M(+45.3%)
-$1.63B(-7.3%)
Mar 1999
-
-$1.02B(+32.4%)
-$1.52B(-353.4%)
Dec 1998
-$335.00M(+67.2%)
-$1.51B(-203.2%)
-$335.00M(-134.7%)
Sep 1998
-
$1.47B(+426.7%)
$966.00M(+244.0%)
Jun 1998
-
-$449.00M(-378.9%)
-$671.00M(-42.5%)
Mar 1998
-
$161.00M(+175.6%)
-$471.00M(+51.1%)
Dec 1997
-$1.02B(-9.1%)
-$213.00M(-25.3%)
-$963.00M(-124.5%)
Sep 1997
-
-$170.00M(+31.7%)
-$429.00M(+61.5%)
Jun 1997
-
-$249.00M(+24.8%)
-$1.11B(+23.0%)
Mar 1997
-
-$331.00M(-203.1%)
-$1.45B(-70.1%)
Dec 1996
-$937.00M(+60.0%)
$321.00M(+137.6%)
-$850.00M(+44.2%)
Sep 1996
-
-$854.00M(-46.7%)
-$1.52B(-116.8%)
Jun 1996
-
-$582.00M(-319.6%)
-$702.50M(-69.8%)
Mar 1996
-
$265.00M(+175.2%)
-$413.70M(+82.3%)
Dec 1995
-$2.34B(-178.8%)
-$352.20M(-957.7%)
-$2.34B(-7.8%)
Sep 1995
-
-$33.30M(+88.6%)
-$2.17B(+5.8%)
Jun 1995
-
-$293.20M(+82.4%)
-$2.31B(+4.7%)
Mar 1995
-
-$1.66B(-809.3%)
-$2.42B(-188.2%)
Dec 1994
-$840.30M(-326.8%)
-$183.00M(-9.8%)
-$840.30M(-47.3%)
Sep 1994
-
-$166.60M(+59.1%)
-$570.30M(-31.9%)
Jun 1994
-
-$407.80M(-391.9%)
-$432.50M(-2199.5%)
Mar 1994
-
-$82.90M(-195.3%)
$20.60M(+110.5%)
Dec 1993
-$196.90M(-150.5%)
$87.00M(+402.1%)
-$196.90M(-413.0%)
Sep 1993
-
-$28.80M(-163.6%)
$62.90M(+169.5%)
Jun 1993
-
$45.30M(+115.1%)
-$90.50M(-3.2%)
Mar 1993
-
-$300.40M(-186.6%)
-$87.70M(-122.5%)
Dec 1992
$389.90M(+411.4%)
$346.80M(+290.3%)
$389.90M(+124.6%)
Sep 1992
-
-$182.20M(-478.8%)
$173.60M(-17.4%)
Jun 1992
-
$48.10M(-72.9%)
$210.10M(+555.7%)
Mar 1992
-
$177.20M(+35.8%)
-$46.10M(+63.2%)
Dec 1991
-$125.20M(+61.9%)
$130.50M(+189.6%)
-$125.20M(+46.1%)
Sep 1991
-
-$145.70M(+30.0%)
-$232.10M(+32.6%)
Jun 1991
-
-$208.10M(-312.1%)
-$344.60M(-4.7%)
Mar 1991
-
$98.10M(+315.7%)
-$329.10M(-0.0%)
Dec 1990
-$329.00M(+37.7%)
$23.60M(+109.1%)
-$329.00M(+6.7%)
Sep 1990
-
-$258.20M(-34.1%)
-$352.60M(-273.5%)
Jun 1990
-
-$192.60M(-296.1%)
-$94.40M(-196.1%)
Mar 1990
-
$98.20M
$98.20M
Dec 1989
-$528.50M(+35.2%)
-
-
Dec 1988
-$815.10M(-162.5%)
-
-
Dec 1987
-$310.50M(-58.3%)
-
-
Dec 1986
-$196.10M(+74.8%)
-
-
Dec 1985
-$778.30M(-571.5%)
-
-
Dec 1984
-$115.90M(+52.7%)
-
-
Dec 1983
-$245.00M(+2.1%)
-
-
Dec 1982
-$250.30M(+5.9%)
-
-
Dec 1981
-$266.10M(-56.4%)
-
-
Dec 1980
-$170.10M
-
-

FAQ

  • What is Pfizer Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Pfizer Inc.?
  • What is Pfizer Inc. annual cash from investing year-on-year change?
  • What is Pfizer Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Pfizer Inc.?
  • What is Pfizer Inc. quarterly cash from investing year-on-year change?
  • What is Pfizer Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Pfizer Inc.?
  • What is Pfizer Inc. TTM cash from investing year-on-year change?

What is Pfizer Inc. annual cash from investing?

The current annual cash from investing of PFE is $2.65B

What is the all-time high annual cash from investing for Pfizer Inc.?

Pfizer Inc. all-time high annual cash from investing is $6.15B

What is Pfizer Inc. annual cash from investing year-on-year change?

Over the past year, PFE annual cash from investing has changed by +$34.93B (+108.22%)

What is Pfizer Inc. quarterly cash from investing?

The current quarterly cash from investing of PFE is $3.95B

What is the all-time high quarterly cash from investing for Pfizer Inc.?

Pfizer Inc. all-time high quarterly cash from investing is $9.67B

What is Pfizer Inc. quarterly cash from investing year-on-year change?

Over the past year, PFE quarterly cash from investing has changed by -$649.00M (-14.11%)

What is Pfizer Inc. TTM cash from investing?

The current TTM cash from investing of PFE is $3.54B

What is the all-time high TTM cash from investing for Pfizer Inc.?

Pfizer Inc. all-time high TTM cash from investing is $6.15B

What is Pfizer Inc. TTM cash from investing year-on-year change?

Over the past year, PFE TTM cash from investing has changed by +$7.32B (+193.88%)
On this page